Veranex Unveils MedTech’s First Innovation CRO (iCRO)—Redefining R&D in a Capital‑Tight Market

RALEIGH, N.C.--(BUSINESS WIRE)-- #CRO--Veranex, a global provider of product development and contract research services, today introduced the industry’s first Innovation CRO (iCRO)—an integrated development and research platform engineered to move medical devices and in-vitro diagnostics (IVDs) from concept to commercial success faster, with tighter budget control and a built-in path to payer adoption. iCRO: Innovation Without Waste The Veranex iCRO model is built on four core pillars: Speed & Cap